57 Analytes57 named target entries · 2 included assays · 57 Analytes
Samples
UrinePreparation tailored to the sample
Results
48 hoursListed laboratory turnaround
Collection
IncludedArrange with the care team
THE PURPOSE BEHIND THE PANEL.
Choose the scope. Understand the result.
The combined package brings together the STD-28 panel and a urinary-organism/resistance panel. Overlapping organisms and gene targets mean the headline count and component totals use different units.
45named targets
45 listed entries
Exact source inventory
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
What this means in context
Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
12named targets
12 listed entries
Genes, not separate infections
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
What this means in context
Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
2laboratory assays
2 included assays
The panels behind the named targets.
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase.
What this means in context
Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
KNOW EXACTLY WHAT YOU ARE CHOOSING.
57 Analytes. The scope, made clear.
The published inventory contains 57 analytes: 45 named organism targets and 12 selected resistance genes. The two component panels overlap, so adding their separate counts would duplicate some entries. A gene is not a separate infection or a complete susceptibility result.
57Analytes
57named target entries2 included assays
UrineListed specimen type
57 named target entries · 2 included assays · 57 Analytes
Browse by group. Search to find a named target.
Named organism targets
45 entries
Chlamydia trachomatis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Neisseria gonorrhoeae
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Varicella Zoster Virus
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Cytomegalovirus
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Lymphogranuloma Venereum
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Candida glabrata
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Candida krusei
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Candida lusitaniae
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Candida parapsilosis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Candida tropicalis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Candida dubliniensis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Atopobium vaginae
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Lactobacillus spp.
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Megasphaera type 1
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Mobiluncus spp.
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Trichomonas vaginalis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Mycoplasma hominis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Mycoplasma genitalium
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Herpes simplex virus type 1
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Herpes simplex virus type 2
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Treponema pallidum
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Haemophilus ducreyi
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Candida albicans
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Gardnerella vaginalis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Acinetobacter baumannii
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Staphylococcus aureus
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Klebsiella pneumoniae
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Morganella morganii
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Staphylococcus saprophyticus
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Pseudomonas aeruginosa
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Enterococcus faecium
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Streptococcus agalactiae
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Enterococcus faecalis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Ureaplasma urealyticum
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Serratia marcescens
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Proteus mirabilis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Escherichia coli
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Klebsiella oxytoca
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Ureaplasma parvum
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Klebsiella aerogenes
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Enterobacter cloacae
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Bacteroides fragilis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Staphylococcus epidermidis
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Citrobacter spp.
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Resistance markers
12 entries
blaKPC
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
blaNDM
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
blaOXA-48
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
blaVIM
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
blaIMP
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
CTX-M
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
mecA
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
vanA
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
vanB
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
sul1
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
sul2
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
sul3
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording.
Included laboratory assays
2 entries
UTI & Drug Resistance Gene PanelExplore the named components
Looks for listed urinary organisms and selected resistance genes. Gene detection is not a full antibiotic-susceptibility result or a treatment prescription.
Try a test or target name, or choose another health focus.
Checking a prescription? Let’s make sure it matches.
THE RIGHT START DEPENDS ON YOU.
A useful package. A personal decision.
Choose the investigation around the question you want to discuss. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
01
A defined question
The combined package brings together the STD-28 panel and a urinary-organism/resistance panel. Overlapping organisms and gene targets mean the headline count and component totals use different units.
02
Matching a prescription
Compare the full included list with your clinician’s request. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
03
Following a previous finding
Bring earlier results and the relevant symptom or treatment history. The clinician can decide whether this scope, a smaller test selection or a different investigation is the most useful next step.
MAKE THE SAMPLE COUNT.
A little preparation. A more useful result.
Preparation follows the actual specimen and tests in Ultimate Sexual Wellness. Confirm your personal instructions before collection.
01
Urine.One coordinated pathway.
YOUR PREPARATION0 of 4 ready
A personal checklist. Your care team confirms the instructions.
YOUR COLLECTION. YOUR CHOICE.
Care comes to you. Or visit your laboratory.
Both routes lead to the same defined package. Choose the location during checkout; this package waives the collection fee for its visit.
YOUR PLACE. THE SAME LABORATORY PATHWAY.
A familiar setting. A professional collection.
Discuss collection at your home, hotel or workplace in Dubai. The care team confirms the appropriate specimen, preparation and collection arrangements for this package.
Collection fee included for this package’s visit
Choose the person and location in the shared checkout
Need another time? Request the earliest available appointment
Across Dubai
THE LABORATORY. READY TO WELCOME YOU.
Your visit. In Deira.
Intel Lab · Deira 101–102, Al Hawai Building, Al Rigga Road, Al Muraqqabat, Deira, Dubai
Follow Ultimate Sexual Wellness from your care bag to an informed conversation.
The right package. The right person.
Choose & assign
Add Ultimate Sexual Wellness to your care bag. Book for yourself or assign the package to someone else. The care team can help match the selection to a request or prescription.
Preparation follows the test.
Prepare & collect
Confirm the instructions for urine and the appropriate collection arrangements. Correct identification, specimen choice and timing support a useful result.
Laboratory work, behind the finding.
Analyse & report
Intel Lab processes the sample and checks the report. The package lists 48 hours; collection timing and any additional laboratory checks may affect release.
A finding, placed in your context.
Understand & follow up
Read the report with the reason for testing. A clinician can explain unexpected findings, relevant limitations and whether any further assessment is appropriate.
MORE THAN A LIST OF NUMBERS.
Read the result. Understand the context.
Your report brings the measurements together. Explore the findings below to see which questions make the report more meaningful.
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
Laboratory informationClinical interpretation
RESULT + CONTEXT
Exact source inventory
This view contains 45 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
Questions to take to your clinician
What does this part of my result add to the clinical question?
Does the sample timing or a medicine affect this finding?
What follow-up is appropriate for this specific result?
UNDERSTANDING YOUR REPORT
Urine
Resistance markers
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
Laboratory informationClinical interpretation
RESULT + CONTEXT
Genes, not separate infections
This view contains 12 entries. Open the full inventory to see exactly what is included; mixtures and grouped targets retain their source wording. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
Questions to take to your clinician
What does this part of my result add to the clinical question?
Does the sample timing or a medicine affect this finding?
What follow-up is appropriate for this specific result?
UNDERSTANDING YOUR REPORT
Urine
Included laboratory assays
The result describes the sample that was tested. Preparation, timing and the measurement method help explain its context.
Laboratory informationClinical interpretation
RESULT + CONTEXT
The panels behind the named targets.
These are the included laboratory tests or panels. Their named targets are shown in the other views; a target is a component of the package, not an additional item to purchase. Resistance genes are not a complete culture-and-susceptibility result. HIV and hepatitis blood tests are not included.
Questions to take to your clinician
What does this part of my result add to the clinical question?
Does the sample timing or a medicine affect this finding?
What follow-up is appropriate for this specific result?
THE NEXT STEP IS PERSONAL.
Bring the findings back to you.
Connect the laboratory findings with the reason for this specific test. A report supports the next clinical conversation; it does not decide it for you.
01
Separate organism detection from treatment selection
Review urinary organisms and any resistance-gene findings with symptoms and the specimen context. Selected genes are not a complete susceptibility result; the clinician may request culture or other follow-up before treatment decisions.
02
Agree the next step
Discuss this result with a clinician who knows the reason for testing. Further investigations or follow-up depend on the actual findings and your circumstances.
Intelligent Care brings the collection to you. Intel Lab brings the laboratory pathway, from sample handling to reporting.
1M+biomarkers reported annually
25+years in medicine · Dr Nirupama
Identify and protect the sample
Accurate patient details, the correct specimen and clear collection instructions are the first part of a reliable laboratory pathway. Follow the collection team’s instructions for the specimens required by this panel.
Analyse with quality controls
The laboratory’s analytical work and quality processes support the measurements in the report. Explore the laboratory’s published quality standards and accreditation scope for the detail behind its services.
Review before the report is released
Reporting connects the laboratory findings with their clinical use. Unexpected or significant results may need additional checks or communication with the referring clinician.
Laboratory content belongs with laboratory expertise. Explore the clinical profiles and their Dubai Health Authority directory records.
Clinical author
Dr Nirupama Sabhapathy
Laboratory Director · Intel Lab
Dr Nirupama Sabhapathy is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her published Intel Lab profile describes more than 25 years in medicine and her role as Laboratory Director.
Dr Joyce Jose is a DHA-licensed Specialist in Clinical Pathology at Intel Lab. Her public professional record includes pathology practice in the UAE and earlier experience as a professor at Gulf Medical University.
Choosing for a particular need? We can help you read the options.
BEFORE YOU BOOK.
A little more clarity.
Preparation, sample types, timing and what the package does—and does not—include.
What is included in Ultimate Sexual Wellness?
Genital and urinary targets in one wider panel. The full named inventory on this page is the scope of the package.
Can the resistance result tell me exactly which antibiotic to take?
No. A detected gene needs organism and clinical context. Culture or other testing may be required; treatment selection belongs with the clinician.
Does molecular detection prove a symptomatic UTI?
Not by itself. Symptoms, the specimen, the organism and other findings determine clinical relevance.
Are resistance genes the same as a full susceptibility test?
No. The listed genes are selected molecular markers. Their presence or absence does not describe susceptibility to every antibiotic.
Can a urine panel assess every genital exposure site?
No. The clinical question and exposure site may require an additional or different specimen.
How should I prepare?
Use the labelled sterile container and confirm handling, collection and transport timing. Tell the team if collection instructions could not be followed.
Can I arrange collection in Dubai?
Yes. Choose home collection across Dubai or a visit to Intel Lab in Deira. Any health package waives the collection fee for its own visit; separate appointments are assessed separately.
What is the price and expected turnaround?
The package price is AED 1499; the listed turnaround is 48 hours. Confirm collection and processing arrangements with the team. Turnaround is not a guarantee that every result will be released at one exact time.
What happens after I receive the result?
Review relevant findings with a qualified clinician alongside the reason for testing, symptoms, medicines and prior results. The report may lead to reassurance about the tested question, confirmation, a targeted investigation or follow-up—not an automatic treatment decision.
YOUR NEXT STEP. AROUND YOU.
A clearer question. A more informed next step.
Ultimate Sexual Wellness · 57 Analytes · Urine
AED1,499collection included for this package’s visit